AYRWF · Ayr Wellness Inc.
Market Cap
$432,062
Shares
116.77M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$463.63M
0%
FY2024
Net Income
-$359.31M
-31.9%
FY2024
Gross Margin
38.11%
-5.6pp
FY2024
Operating Margin
-34.72%
-26.7pp
FY2024
Diluted EPS
-$3.24
+12%
FY2024
Operating Cash Flow
$9.63M
-64.5%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| $463.63M | $463.63M | $421.44M | $357.61M | $155.11M | $75.2M | |
| $286.95M | $261.19M | $246.47M | — | $66.56M | $40.77M | |
| $176.68M | $202.44M | $174.97M | $138.1M | $88.76M | $26.26M | |
| 38.11% | 43.66% | 41.52% | 38.62% | 57.22% | 34.92% | |
| — | — | — | $136.74M | $69.58M | $19.04M | |
| $167.13M | $177.8M | $212.53M | — | — | — | |
| $58.07M | $58.65M | $57.12M | — | — | — | |
| $28.23M | $32.3M | $19.03M | $40.66M | $829.75K | $1.39M | |
| $337.67M | $239.56M | $382.25M | — | — | — | |
| -$160.99M | -$37.12M | -$207.29M | -$56.01M | $1.23M | -$37.47M | |
| -34.72% | -8.01% | -49.19% | -15.66% | 0.79% | -49.83% | |
| -$132.76M | -$4.82M | -$188.26M | -$15.35M | $2.06M | -$36.07M | |
| $78.26M | $39.4M | $28.32M | — | — | — | |
| -$158.1M | -$8.63M | $35.16M | — | — | — | |
| -$319.09M | -$45.76M | -$172.13M | $12.31M | -$2.52M | -$159.34M | |
| $43.27M | $47.39M | $44.75M | $29.26M | $22.09M | $4.84M | |
| -$359.31M | -$272.43M | -$245.47M | -$16.95M | -$24.61M | -$164.18M | |
| -77.5% | -58.76% | -58.25% | -4.74% | -15.86% | -218.34% | |
| -$3.05M | -$7.07M | -$10.02M | — | — | — | |
| USD/shares | -$3.24 | -$3.68 | -$3.58 | -$0.30 | -$0.88 | — |
| USD/shares | -$3.24 | -$3.68 | -$3.58 | -$0.30 | -$0.88 | — |
| shares | 110.83K | 74.1K | 68.64K | — | — | — |
| shares | 110.83K | 74.1K | 68.64K | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Drug Manufacturers - Specialty & Generic median 2.08×
EV/EBIT
—
Drug Manufacturers - Specialty & Generic median 19.68×
P/E (TTM)
—
Drug Manufacturers - Specialty & Generic median 17.79×